LNAI · Forms 3, 4, 5
Insider trades at Lunai Bioworks
No Form 3, 4 or 5 filings at Lunai Bioworks in the last 90 days.
Every Form 3, 4 and 5 filed for Lunai Bioworks (LNAI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Lunai Bioworks in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Anderson Wittekind William | 10% owner | Other | 350,000 | Form 4 | |||
| Nathen Fuentes | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Maurice van Tilburg | Director | Award | 250,000 | Form 4 | |||
| Nathen Fuentes | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Mark Anthony Collins | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.